abdominal pain glp-1 nausea: How to handle GLP-1s' most common side effect Severe Stomach Paralysis Linked to
Description
The prevalence of obesity in older adults (people aged >60 years) is increasing in line with the demographic shift in global populations
A new blockbuster class of therapeutics, glucagon-like peptide 1 (GLP-1) analogs (eg, semaglutide), shows promise at curbing both diseases
Why Choose elife for Medically Supervised Weight Care
Thus, oral administration of a peptide therapeutic represents a significant advance in medicine, but is challenged by gastrointestinal instability and ineffective uptake into the circulation
